“…Results of these investigations are reported for: (i) Cineraria grandiflora: sesquiterpenes and acetylenic compounds (Bohlmann and Abraham, 1978); polyacetylenic compounds (Bohlmann and Zdero, 1983); acetylenic compounds (Lehmann et al, 1988), (ii) Clutia abyssinica: macrocyclic diterpenes (Aylward et al, 2001a,b;Aylward and Parsons, 2002); coumarins (Waigh et al, 1991); diterpenes (Waigh et al, 1990); antiplasmodial activity of lipophilic extracts (Kraft et al, 2003), (iii) Coccinia adoensis: antimutagenic and anticarcinogenic potential (Kusamran et al, 1998), (iv) Marattia fraxinea: flavonoids (Voirin, 1970), (v) Pavonia urens: antifungal properties (Dayal and Purohit, 1971), and (vi) Vangueria infausta: anthelmintic action (Teichler, 1935); antiplasmodial activity (Nundkumar and Ojewole, 2002). The other plants with medicinal uses (Table 1), or relatives to these, have also been previously studied although not always for the same applications (van Puyvelde et al, 1980;Hussain and Deeni, 1991;Desta, 1993;Taniguchi and Kubo, 1993;Ndounga et al, 1994;Vlietinck et al, 1995;Hamill et al, 2000Hamill et al, , 2003. Additionally, the toxicity of some of the extracts/active ingredients was tested in a range of animal systems, which revealed that most of them had diverse side effects and toxic doses varied greatly (Fernando and Fernando, 1990;Vanhaelen et al, 1994;Igile et al, 1995).…”